PROMETHEUS BIOSCIENCES INC's ticker is RXDX and the CUSIP is 74349U108.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2023 | $1,494,002 | -93.9% | 13,921 | -93.7% | 0.62% | -91.2% |
Q4 2022 | $24,464,000 | +102.5% | 222,400 | +8.6% | 7.00% | +71.3% |
Q3 2022 | $12,079,000 | +41.8% | 204,700 | -32.2% | 4.09% | +55.8% |
Q2 2022 | $8,517,000 | +3008.4% | 301,700 | +1911.3% | 2.62% | +1659.7% |
Q1 2021 | $274,000 | – | 15,000 | – | 0.15% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
72 Investment Holdings, LLC | 1,848,024 | $203,282,640 | 93.46% |
CHI Advisors LLC | 923,800 | $101,618,000 | 27.06% |
Sio Capital Management, LLC | 574,200 | $63,162,000 | 23.36% |
Cormorant Asset Management, LP | 2,090,000 | $229,900 | 15.38% |
Boxer Capital, LLC | 1,897,500 | $208,725,000 | 11.00% |
SEVEN GRAND MANAGERS, LLC | 20,105 | $2,211,550 | 10.34% |
Decheng Capital Management III (Cayman), LLC | 250,000 | $27,500,000 | 10.29% |
Ikarian Capital, LLC | 288,926 | $31,781,860 | 7.67% |
RTW INVESTMENTS, LP | 3,354,303 | $368,973,330 | 7.53% |
Waypoint Capital Advisors, LLC | 171,181 | $18,829,910 | 6.53% |